Clinical trial
A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors
NCT02442414 is registered in ClinicalTrials.gov with Sihuan Pharmaceutical Holdings Group Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors
- Lead sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 7, 2015
- Completion date
- November 26, 2019
- Enrollment
- 35 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
advanced solid tumors